Amrita Krishnan, MD, discusses the future of isatuximab in the treatment of relapsed/refractory MM OBRoncology 1:30 5 years ago 41 Далее Скачать
Amrita Krishnan M.D., on Treatment Options for Multiple Myeloma | #ASCO21 City of Hope 1:17 3 years ago 155 Далее Скачать
Amrita Krishnan, M.D., Discusses a New Class of Myeloma Therapies | #ASCO21 City of Hope 1:32 3 years ago 210 Далее Скачать
Dr. Krishnan on Key Aspects of the ELOQUENT Trials in Relapsed/Refractory Multiple Myeloma OncLive 1:16 5 years ago 87 Далее Скачать
First-in-human study of talquetamab: a GPRC5D-CD3 bispecific antibody for R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 2:25 4 years ago 173 Далее Скачать
Isatuximab for multiple myeloma - promising results and next steps VJHemOnc – Video Journal of Hematology & HemOnc 2:20 8 years ago 736 Далее Скачать
Meet Multiple Myeloma Specialist Amrita Krishnan, M.D. | City of Hope Orange County City of Hope Orange County 1:45 4 years ago 495 Далее Скачать
The future of multiple myeloma treatment VJHemOnc – Video Journal of Hematology & HemOnc 1:54 8 years ago 169 Далее Скачать
The efficacy of cevostamab in R/R multiple myeloma and the importance of bispecific antibodies VJHemOnc – Video Journal of Hematology & HemOnc 1:38 2 years ago 85 Далее Скачать
Safety & efficacy of isatuximab, pomalidomide and dexamethasone in frail patients with R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:50 1 year ago 102 Далее Скачать
Teclistamab’s place in the myeloma treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 0:41 2 years ago 110 Далее Скачать
Mezagitamab: an anti-CD38 antibody for R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 1:14 5 years ago 241 Далее Скачать
Dr. Amrita Krishnan: Virtual NBC4 Broadcast | City of Hope Orange County City of Hope Orange County 2:15 4 years ago 236 Далее Скачать
Amrita Krishnan, MD on the Best Myeloma Maintenance Approach After Transplant — IMW 2019 HealthTree Foundation for Multiple Myeloma 2:16 5 years ago 536 Далее Скачать
Can novel immunotherapies cure multiple myeloma? VJHemOnc – Video Journal of Hematology & HemOnc 3:41 3 years ago 3 539 Далее Скачать
Bispecific BCMA-CD3 antibody teclistamab is efficacious and tolerable in R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 1:29 4 years ago 87 Далее Скачать
MonumenTAL-1: updated data on talquetamab in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:47 3 years ago 110 Далее Скачать
